Access Statistics for Márta Péntek

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? 0 0 1 26 0 0 3 23
Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists 0 0 0 28 0 1 6 54
Total Working Papers 0 0 1 54 0 1 9 77


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective 0 0 0 1 0 1 3 27
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries 1 1 1 7 2 3 7 34
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries 0 0 1 6 0 1 8 55
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis 1 1 1 3 1 1 3 34
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study 0 0 0 3 0 2 8 64
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison 0 0 0 2 0 0 1 26
Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary 0 0 0 3 0 0 0 38
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary 0 0 0 4 0 1 4 40
HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain 0 0 0 7 0 0 2 28
Health economics and health technology assessment in Central and Eastern Europe: a dose of reality 0 0 0 12 0 0 0 38
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 0 0 2 3 0 1 8 28
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe 0 0 0 5 1 1 4 28
Social/economic costs and health-related quality of life in patients with histiocytosis in Europe 0 0 0 1 1 1 3 14
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe 0 0 1 2 0 1 4 21
Social/economic costs and health-related quality of life in patients with scleroderma in Europe 0 0 1 3 0 1 7 29
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe 0 0 1 1 0 1 5 29
Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists 0 0 0 3 0 0 3 26
The disease burden of colorectal cancer in Hungary 0 0 0 22 1 2 9 120
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? 0 0 0 6 0 0 5 27
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries 0 0 0 0 0 0 1 16
Total Journal Articles 2 2 8 94 6 17 85 722


Statistics updated 2019-07-03